The role of tristetraprolin in cancer and inflammation

Frontiers in Bioscience

Volumn 17, Issue 1, 2012, Pages 174-188

  Sanduja, Sandhya ^a   Blanco, Fernando F ^a   Young, Lisa E ^b   Kaza, Vimala ^a   Dixon, Dan A ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

AU rich element; mRNA decay; Post transcriptional regulation; Review; Tristetraprolin

Indexed keywords

EID: 84860349850     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3920     Document Type: Review

References (121)

1. N. L. Garneau, J. Wilusz and C. J. Wilusz: The highways and byways of mRNA decay. Nat Rev Mol Cell Biol 8, 113-126 (2007) (Pubitemid 46432531)
2. D. Benjamin and C. Moroni: mRNA stability and cancer: An emerging link? Expert Opin Biol Ther 7, 1515-1529 (2007) (Pubitemid 47597140)
3. I. Lopez de Silanes, M. P. Quesada and M. Esteller: Aberrant regulation of messenger RNA 3'-untranslated region in human cancer. Cell Oncol 29, 1-17 (2007) (Pubitemid 46535188)
4. T. Bakheet, B. R. Williams and K. S. Khabar: Ared 3.0: The large and diverse AU-rich transcriptome. Nucleic Acids Res 34, D111-114 (2006)
5. S. Sanduja, F. F. Blanco and D. A. Dixon: The roles of TTP and BRF proteins in regulated mRNA decay. Wiley Interdisciplinary Reviews -RNA, in press (2010)
6. R. N. DuBois, M. W. McLane, K. Ryder, L. F. Lau and D. Nathans: A growth factor-inducible nuclear protein with a novel cysteine/histidine repetitive sequence. J Biol Chem 265, 19185-19191 (1990)
7. W. S. Lai, D. J. Stumpo and P. J. Blackshear: Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J Biol Chem 265, 16556-16563 (1990)
8. Q. Ma and H. R. Herschman: A corrected sequence for the predicted protein from the mitogen-inducible TIS11 primary response gene. Oncogene 6, 1277-1278 (1991) (Pubitemid 21924218)
9. B. C. Varnum, R. W. Lim, V. P. Sukhatme and H. R. Herschman: Nucleotide sequence of a cdna encoding TIS11, a message induced in swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate. Oncogene 4, 119-120 (1989) (Pubitemid 19085080)
10. E. Carballo, W. S. Lai and P. J. Blackshear: Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281, 1001-1005 (1998) (Pubitemid 28399252)
11. N. Kaneda, M. Oshima, S. Y. Chung and G. Guroff: Sequence of a rat TIS11 cdna, an immediate early gene induced by growth factors and phorbol esters. Gene 118, 289-291 (1992)
12. G. A. Taylor, W. S. Lai, R. J. Oakey, M. F. Seldin, T. B. Shows, R. L. Eddy, Jr. and P. J. Blackshear: The human TTP protein: Sequence, alignment with related proteins, and chromosomal localization of the mouse and human genes. Nucleic Acids Res 19, 3454 (1991)
13. B. C. Varnum, Q. F. Ma, T. H. Chi, B. Fletcher and H. R. Herschman: The TIS11 primary response gene is a member of a gene family that encodes proteins with a highly conserved sequence containing an unusual cys-his repeat. Mol Cell Biol 11, 1754-1758 (1991) (Pubitemid 21895539)
14. M. Gomperts, J. C. Pascall and K. D. Brown: The nucleotide sequence of a cdna encoding an EGF-inducible gene indicates the existence of a new family of mitogeninduced genes. Oncogene 5, 1081-1083 (1990)
15. N. Kaneda, T. Murata, Y. Niimi and M. Minamiyama: Cloning and characterization of the rat TIS11 gene. Mol Cell Biochem 213, 119-126 (2000)
16. W. S. Lai, M. J. Thompson and P. J. Blackshear: Characteristics of the intron involvement in the mitogeninduced expression of ZFP-36. J Biol Chem 273, 506-517 (1998) (Pubitemid 28042238)
17. W. S. Lai, M. J. Thompson, G. A. Taylor, Y. Liu and P. J. Blackshear: Promoter analysis of ZFP-36, the mitogeninducible gene encoding the zinc finger protein tristetraprolin. J Biol Chem 270, 25266-25272 (1995)
18. K. Ogawa, F. Chen, Y. J. Kim and Y. Chen: Transcriptional regulation of tristetraprolin by transforming growth factor-beta in human T cells. J Biol Chem 278, 30373-30381 (2003) (Pubitemid 36962432)
19. H. Cao, M. A. Kelly, F. Kari, H. D. Dawson, J. F. Urban, Jr., S. Coves, A. M. Roussel and R. A. Anderson: Green tea increases anti-inflammatory tristetraprolin and decreases pro-inflammatory tumor necrosis factor mRNA levels in rats. J Inflamm 4, 1 (2007)
20. H. Cao, M. M. Polansky and R. A. Anderson: Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-l1 adipocytes. Arch Biochem Biophys 459, 214-222 (2007) (Pubitemid 46389602)
21. F. T. Ishmael, X. Fang, M. R. Galdiero, U. Atasoy, W. F. Rigby, M. Gorospe, C. Cheadle and C. Stellato: Role of the RNA-binding protein tristetraprolin in glucocorticoidmediated gene regulation. J Immunol 180, 8342-8353 (2008)
22. I. Sauer, B. Schaljo, C. Vogl, I. Gattermeier, T. Kolbe, M. Muller, P. J. Blackshear and P. Kovarik: Interferons limit inflammatory responses by induction of tristetraprolin. Blood 107, 4790-4797 (2006) (Pubitemid 43882630)
23. K. Smoak and J. A. Cidlowski: Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling. Mol Cell Biol 26, 9126-9135 (2006) (Pubitemid 44851967)
24. C. R. Tchen, M. Brook, J. Saklatvala and A. R. Clark: The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself. J Biol Chem 279, 32393-32400 (2004) (Pubitemid 39014693)
25. J. L. Dean, S. J. Sarsfield, E. Tsounakou and J. Saklatvala: p38 mitogen-activated protein kinase stabilizes mRNAs that contain cyclooxygenase-2 and tumor necrosis factor AU-rich elements by inhibiting deadenylation. J Biol Chem 278, 39470-39476 (2003) (Pubitemid 37248503)
26. R. S. Phillips, S. B. Ramos and P. J. Blackshear: Members of the tristetraprolin family of tandem ccch zinc finger proteins exhibit CRM1-dependent nucleocytoplasmic shuttling. J Biol Chem 277, 11606-11613 (2002) (Pubitemid 34952933)
27. W. S. Lai, E. Carballo, J. R. Strum, E. A. Kennington, R. S. Phillips and P. J. Blackshear: Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol 19, 4311-4323 (1999) (Pubitemid 29242006)
28. G. A. Taylor, M. J. Thompson, W. S. Lai and P. J. Blackshear: Mitogens stimulate the rapid nuclear to cytosolic translocation of tristetraprolin, a potential zincfinger transcription factor. Mol Endocrinol 10, 140-146 (1996) (Pubitemid 26042546)
29. G. A. Taylor, M. J. Thompson, W. S. Lai and P. J. Blackshear: Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen-activated protein kinase in vitro. J Biol Chem 270, 13341-13347 (1995)
30. H. Cao, L. J. Deterding, J. D. Venable, E. A. Kennington, J. R. Yates, 3rd, K. B. Tomer and P. J. Blackshear: Identification of the anti-inflammatory protein tristetraprolin as a hyperphosphorylated protein by mass spectrometry and site-directed mutagenesis. Biochem J 394, 285-297 (2006) (Pubitemid 43259679)
31. H. Cao: Expression, purification, and biochemical characterization of the antiinflammatory tristetraprolin: A zinc-dependent mRNA binding protein affected by posttranslational modifications. Biochemistry 43, 13724-13738 (2004) (Pubitemid 39431056)
32. H. Cao, L. J. Deterding and P. J. Blackshear: Phosphorylation site analysis of the anti-inflammatory and mRNA-destabilizing protein tristetraprolin. Expert Rev Proteomics 4, 711-726 (2007) (Pubitemid 350261438)
33. H. Cao, F. Dzineku and P. J. Blackshear: Expression and purification of recombinant tristetraprolin that can bind to tumor necrosis factor-alpha mRNA and serve as a substrate for mitogen-activated protein kinases. Arch Biochem Biophys 412, 106-120 (2003) (Pubitemid 36324370)
34. E. Carballo, H. Cao, W. S. Lai, E. A. Kennington, D. Campbell and P. J. Blackshear: Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway. J Biol Chem 276, 42580-42587 (2001)
35. C. A. Chrestensen, M. J. Schroeder, J. Shabanowitz, D. F. Hunt, J. W. Pelo, M. T. Worthington and T. W. Sturgill: Mapkap kinase 2 phosphorylates tristetraprolin on in vivo sites including ser178, a site required for 14-3-3 binding. J Biol Chem 279, 10176-10184 (2004) (Pubitemid 38372622)
36. K. R. Mahtani, M. Brook, J. L. Dean, G. Sully, J. Saklatvala and A. R. Clark: Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol 21, 6461-6469 (2001) (Pubitemid 32927414)
37. W. Zhu, M. A. Brauchle, F. Di Padova, H. Gram, L. New, K. Ono, J. S. Downey and J. Han: Gene suppression by tristetraprolin and release by the p38 pathway. Am J Physiol Lung Cell Mol Physiol 281, L499-508 (2001)
38. B. A. Johnson, J. R. Stehn, M. B. Yaffe and T. K. Blackwell: Cytoplasmic localization of tristetraprolin involves 14-3-3-dependent and -independent mechanisms. J Biol Chem 277, 18029-18036 (2002) (Pubitemid 34967615)
39. G. Stoecklin, T. Stubbs, N. Kedersha, S. Wax, W. F. Rigby, T. K. Blackwell and P. Anderson: Mk2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J 23, 1313-1324 (2004) (Pubitemid 38525003)
40. L. Sun, G. Stoecklin, S. Van Way, V. Hinkovska-Galcheva, R. F. Guo, P. Anderson and T. P. Shanley: Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J Biol Chem 282, 3766-3777 (2007) (Pubitemid 47084478)
41. E. Hitti, T. Iakovleva, M. Brook, S. Deppenmeier, A. D. Gruber, D. Radzioch, A. R. Clark, P. J. Blackshear, A. Kotlyarov and M. Gaestel: Mitogen-activated protein kinaseactivated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol 26, 2399-2407 (2006) (Pubitemid 43346938)
42. F. P. Marchese, A. Aubareda, C. Tudor, J. Saklatvala, A. R. Clark and J. L. Dean: Mapkap kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting caf1 deadenylase recruitment. J Biol Chem 285, 27590-27600 (2010)
43. G. A. Taylor, E. Carballo, D. M. Lee, W. S. Lai, M. J. Thompson, D. D. Patel, D. I. Schenkman, G. S. Gilkeson, H. E. Broxmeyer, B. F. Haynes and P. J. Blackshear: A pathogenetic role for tnf alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4, 445-454 (1996) (Pubitemid 26354654)
44. P. J. Blackshear, W. S. Lai, E. A. Kennington, G. Brewer, G. M. Wilson, X. Guan and P. Zhou: Characteristics of the interaction of a synthetic human tristetraprolin tandem zinc finger peptide with AU-rich element-containing rna substrates. J Biol Chem 278, 19947-19955 (2003) (Pubitemid 36799186)
45. B. Y. Brewer, J. Malicka, P. J. Blackshear and G. M. Wilson: Rna sequence elements required for high affinity binding by the zinc finger domain of tristetraprolin: Conformational changes coupled to the bipartite nature of AU-rich mRNA-destabilizing motifs. J Biol Chem 279, 27870-27877 (2004) (Pubitemid 38900055)
46. B. P. Hudson, M. A. Martinez-Yamout, H. J. Dyson and P. E. Wright: Recognition of the mRNA AU-rich element by the zinc finger domain of TIS11d. Nat Struct Mol Biol 11, 257-264 (2004) (Pubitemid 38282771)
47. W. S. Lai and P. J. Blackshear: Interactions of ccch zinc finger proteins with mRNA: Tristetraprolinmediated AU-rich element-dependent mRNA degradation can occur in the absence of a poly(A) tail. J Biol Chem 276, 23144-23154 (2001)
48. W. S. Lai, E. Carballo, J. M. Thorn, E. A. Kennington and P. J. Blackshear: Interactions of ccch zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to AU-rich elements and destabilization of mRNA. J Biol Chem 275, 17827-17837 (2000) (Pubitemid 30430835)
49. M. T. Worthington, J. W. Pelo, M. A. Sachedina, J. L. Applegate, K. O. Arseneau and T. T. Pizarro: Rna binding properties of the AU-rich element-binding recombinant nup475/TIS11/tristetraprolin protein. J Biol Chem 277, 48558-48564 (2002) (Pubitemid 35470816)
50. W. S. Lai, E. A. Kennington and P. J. Blackshear: Interactions of ccch zinc finger proteins with mRNA: Nonbinding tristetraprolin mutants exert an inhibitory effect on degradation of AU-rich element-containing mRNAs. J Biol Chem 277, 9606-9613 (2002) (Pubitemid 34953050)
51. W. S. Lai, E. A. Kennington and P. J. Blackshear: Tristetraprolin and its family members can promote the cell-free deadenylation of AU-rich element-containing mRNAs by poly(A) ribonuclease. Mol Cell Biol 23, 3798-3812 (2003) (Pubitemid 36597460)
52. E. Carballo, W. S. Lai and P. J. Blackshear: Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95, 1891-1899 (2000) (Pubitemid 30151623)
53. D. Frasca, A. M. Landin, J. P. Alvarez, P. J. Blackshear, R. L. Riley and B. B. Blomberg: Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of e47 mRNA. J Immunol 179, 918-927 (2007)
54. H. Sawaoka, D. A. Dixon, J. A. Oates and O. Boutaud: Tristetrapolin binds to the 3' untranslated region of cyclooxygenase-2 mRNA: A polyadenylation variant in a cancer cell line lacks the binding site. J Biol Chem 278, 13928-13935 (2003) (Pubitemid 36799934)
55. E. Suswam, Y. Li, X. Zhang, G. Y. Gillespie, X. Li, J. J. Shacka, L. Lu, L. Zheng and P. H. King: Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells. Cancer Res 68, 674-682 (2008) (Pubitemid 351206742)
56. A. Yamashita, T. C. Chang, Y. Yamashita, W. Zhu, Z. Zhong, C. Y. Chen and A. B. Shyu: Concerted action of poly(A) nucleases and decapping enzyme in mammalian mRNA turnover. Nature Struct Mol Biol 12, 1054-1063 (2005) (Pubitemid 41746775)
57. A. Eulalio, I. Behm-Ansmant and E. Izaurralde: P bodies: At the crossroads of post-transcriptional pathways. Nat Rev Mol Cell Biol 8, 9-22 (2007) (Pubitemid 46012011)
58. C. Y. Chen, R. Gherzi, S. E. Ong, E. L. Chan, R. Raijmakers, G. J. Pruijn, G. Stoecklin, C. Moroni, M. Mann and M. Karin: AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107, 451-464 (2001) (Pubitemid 33152781)
59. N. Cougot, S. Babajko and B. Seraphin: Cytoplasmic foci are sites of mRNA decay in human cells. J Cell Biol 165, 31-40 (2004) (Pubitemid 38649174)
60. P. Mitchell and D. Tollervey: mRNA stability in eukaryotes. Curr Opin Genet Dev 10, 193-198 (2000) (Pubitemid 30182253)
61. L. Ding, A. Spencer, K. Morita and M. Han: The developmental timing regulator ain-1 interacts with miriscs and may target the argonaute protein ALG-1 to cytoplasmic P bodies in C. elegans. Mol Cell 19, 437-447 (2005) (Pubitemid 41140002)
62. M. A. Ferraiuolo, S. Basak, J. Dostie, E. L. Murray, D. R. Schoenberg and N. Sonenberg: A role for the eIF4ebinding protein 4e-T in P-body formation and mRNA decay. J Cell Biol 170, 913-924 (2005) (Pubitemid 41306291)
63. J. Liu, M. A. Valencia-Sanchez, G. J. Hannon and R. Parker: MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 7, 719-723 (2005) (Pubitemid 40975754)
64. R. S. Pillai, S. N. Bhattacharyya, C. G. Artus, T. Zoller, N. Cougot, E. Basyuk, E. Bertrand and W. Filipowicz: Inhibition of translational initiation by let-7 microrna in human cells. Science 309, 1573-1576 (2005) (Pubitemid 41266485)
65. G. L. Sen and H. M. Blau: Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat Cell Biol 7, 633-636 (2005) (Pubitemid 40796987)
66. M. Fenger-Gron, C. Fillman, B. Norrild and J. Lykke-Andersen: Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping. Mol Cell 20, 905-915 (2005) (Pubitemid 41814879)
67. H. H. Hau, R. J. Walsh, R. L. Ogilvie, D. A. Williams, C. S. Reilly and P. R. Bohjanen: Tristetraprolin recruits functional mRNA decay complexes to ARE sequences. J Cell Biochem 100, 1477-1492 (2007) (Pubitemid 46515580)
68. J. Lykke-Andersen and E. Wagner: Recruitment and activation of mRNA decay enzymes by two AREmediated decay activation domains in the proteins TTP and BRF-1. Genes Dev 19, 351-361 (2005) (Pubitemid 40189298)
69. T. M. Franks and J. Lykke-Andersen: TTP and BRF proteins nucleate processing body formation to silence mRNAs with AU-rich elements. Genes Dev 21, 719-735 (2007) (Pubitemid 46440293)
70. P. Anderson and N. Kedersha: Stress granules: The tao of RNA triage. Trends Biochem Sci 33, 141-150 (2008)
71. T. Murata, N. Morita, K. Hikita, K. Kiuchi and N. Kaneda: Recruitment of mRNA-destabilizing protein TIS11 to stress granules is mediated by its zinc finger domain. Exp Cell Res 303, 287-299 (2005) (Pubitemid 40126263)
72. P. Anderson and N. Kedersha: RNA granules. J Cell Biol 172, 803-808 (2006)
73. N. Kedersha, G. Stoecklin, M. Ayodele, P. Yacono, J. Lykke-Andersen, M. J. Fritzler, D. Scheuner, R. J. Kaufman, D. E. Golan and P. Anderson: Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J Cell Biol 169, 871-884 (2005) (Pubitemid 41002864)
74. Q. Jing, S. Huang, S. Guth, T. Zarubin, A. Motoyama, J. Chen, F. Di Padova, S. C. Lin, H. Gram and J. Han: Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120, 623-634 (2005) (Pubitemid 40343075)
75. E. Douni, K. Akassoglou, L. Alexopoulou, S. Georgopoulos, S. Haralambous, S. Hill, G. Kassiotis, D. Kontoyiannis, M. Pasparakis, D. Plows, L. Probert and G. Kollias: Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis. J Inflamm 47, 27-38 (1995) (Pubitemid 26376199)
76. J. Keffer, L. Probert, H. Cazlaris, S. Georgopoulos, E. Kaslaris, D. Kioussis and G. Kollias: Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis. EMBO J 10, 4025-4031 (1991) (Pubitemid 21905432)
77. E. Carballo, G. S. Gilkeson and P. J. Blackshear: Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. Evidence that monocyte/macrophage progenitors may be responsible for TNF-alpha overproduction. J Clin Invest 100, 986-995 (1997) (Pubitemid 27386282)
78. K. Phillips, N. Kedersha, L. Shen, P. J. Blackshear and P. Anderson: Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor alpha, cyclooxygenase 2, and inflammatory arthritis. Proc Natl Acad Sci USA 101, 2011-2016 (2004) (Pubitemid 38229006)
79. A. Tsutsumi, E. Suzuki, Y. Adachi, H. Murata, D. Goto, S. Kojo, I. Matsumoto, L. Zhong, H. Nakamura and T. Sumida: Expression of tristetraprolin (G0S24) mRNA, a regulator of tumor necrosis factor-alpha production, in synovial tissues of patients with rheumatoid arthritis. J Rheumatol 31, 1044-1049 (2004) (Pubitemid 38715877)
80. D. M. Carrick, P. Chulada, R. Donn, M. Fabris, J. McNicholl, W. Whitworth and P. J. Blackshear: Genetic variations in ZFP36 and their possible relationship to autoimmune diseases. J Autoimmun 26, 182-196 (2006) (Pubitemid 43737331)
81. T. Suzuki, A. Tsutsumi, H. Suzuki, E. Suzuki, M. Sugihara, Y. Muraki, T. Hayashi, Y. Chino, D. Goto, I. Matsumoto, S. Ito, K. Miyazawa and T. Sumida: Tristetraprolin (TTP) gene polymorphisms in patients with rheumatoid arthritis and healthy individuals. Mod Rheumatol 18, 472-479 (2008)
82. H. Hsu, J. Xiong and D. V. Goeddel: The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81, 495-504 (1995)
83. J. Liang, T. Lei, Y. Song, N. Yanes, Y. Qi and M. Fu: Rnadestabilizing factor tristetraprolin negatively regulates NFkappaB signaling. J Biol Chem 284, 29383-29390 (2009)
84. Y. M. Schichl, U. Resch, R. Hofer-Warbinek and R. de Martin: Tristetraprolin impairs NF-kappaB/p65 nuclear translocation. J Biol Chem 284, 29571-29581 (2009)
85. L. B. Nabors, G. Y. Gillespie, L. Harkins and P. H. King: Hur, an rna stability factor, is expressed in malignant brain tumors and binds to adenine-and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res 61, 2154-2161 (2001) (Pubitemid 32692041)
86. S. E. Brennan, Y. Kuwano, N. Alkharouf, P. J. Blackshear, M. Gorospe and G. M. Wilson: The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res 69, 5168-5176 (2009)
87. C. A. Gebeshuber, K. Zatloukal and J. Martinez: miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 10, 400-405 (2009)
88. G. Stoecklin, B. Gross, X. F. Ming and C. Moroni: A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA. Oncogene 22, 3554-3561 (2003) (Pubitemid 36765315)
89. N. Al-Souhibani, W. Al-Ahmadi, J. E. Hesketh, P. J. Blackshear and K. S. Khabar: The rna-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes. Oncogene 29, 4205-4215 (2010)
90. X. Liu, H. Yuan, B. Fu, G. L. Disbrow, T. Apolinario, V. Tomaic, M. L. Kelley, C. C. Baker, J. Huibregtse and R. Schlegel: The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. J Biol Chem 280, 10807-10816 (2005) (Pubitemid 40395944)
91. M. Scheffner, B. A. Werness, J. M. Huibregtse, A. J. Levine and P. M. Howley: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136 (1990) (Pubitemid 120035062)
92. D. M. Carrick and P. J. Blackshear: Comparative expression of tristetraprolin (TTP) family member transcripts in normal human tissues and cancer cell lines. Arch Biochem Biophys 462, 278-285 (2007) (Pubitemid 46856329)
93. S. Sanduja, V. Kaza and D. A. Dixon: The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase. Aging 1, 803-817 (2009)
94. B. A. Johnson and T. K. Blackwell: Multiple tristetraprolin sequence domains required to induce apoptosis and modulate responses to TNF-alpha through distinct pathways. Oncogene 21, 4237-4246 (2002) (Pubitemid 34753830)
95. B. A. Johnson, M. Geha and T. K. Blackwell: Similar but distinct effects of the tristetraprolin/TIS11 immediateearly proteins on cell survival. Oncogene 19, 1657-1664 (2000) (Pubitemid 30200967)
96. D. A. Dixon, N. D. Tolley, P. H. King, L. B. Nabors, T. M. McIntyre, G. A. Zimmerman and S. M. Prescott: Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest 108, 1657-1665 (2001) (Pubitemid 33144876)
97. I. Lopez de Silanes, J. Fan, X. Yang, A. B. Zonderman, O. Potapova, E. S. Pizer and M. Gorospe: Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 22, 7146-7154 (2003) (Pubitemid 37378547)
98. L. E. Young and D. A. Dixon: Posttranscriptional regulation of cyclooxygenase 2 expression in colorectal cancer. Curr Colorectal Cancer Rep 6, 60-67 (2010)
99. C. L. Kanies, J. J. Smith, C. Kis, C. Schmidt, S. Levy, K. S. Khabar, J. Morrow, N. Deane, D. A. Dixon and R. D. Beauchamp: Oncogenic ras and transforming growth factor-beta synergistically regulate AU-rich element-containing mRNAs during epithelial to mesenchymal transition. Mol Cancer Res 6, 1124-1136 (2008)
100. L. E. Young, S. Sanduja, K. Bemis-Standoli, E. A. Pena, R. L. Price and D. A. Dixon: The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis. Gastroenterology 136, 1669-1679 (2009)
101. H. H. Lee, Y. J. Son, W. H. Lee, Y. W. Park, S. W. Chae, W. J. Cho, Y. M. Kim, H. J. Choi, D. H. Choi, S. W. Jung, Y. J. Min, S. E. Park, B. J. Lee, H. J. Cha and J. W. Park: Tristetraprolin regulates expression of VEGF and tumorigenesis in human colon cancer. Int J Cancer (2009)
102. B. H. Sohn, I. Y. Park, J. J. Lee, S. J. Yang, Y. J. Jang, K. C. Park, D. J. Kim, D. C. Lee, H. A. Sohn, T. W. Kim, H. S. Yoo, J. Y. Choi, Y. S. Bae and Y. I. Yeom: Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter. Gastroenterology 138, 1898-1908 (2010)
103. K. Masuda, B. Marasa, J. L. Martindale, M. K. Halushka and M. Gorospe: Tissue-and age-dependent expression of RNA-binding proteins that influence mRNA turnover and translation. Aging 1, 681-698 (2009)
104. J. Emmons, W. H. Townley-Tilson, K. M. Deleault, S. J. Skinner, R. H. Gross, M. L. Whitfield and S. A. Brooks: Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation. RNA 14, 888-902 (2008) (Pubitemid 351574911)
105. W. D. Patino, J. G. Kang, S. Matoba, O. Y. Mian, B. R. Gochuico and P. M. Hwang: Atherosclerotic plaque macrophage transcriptional regulators are expressed in blood and modulated by tristetraprolin. Circ Res 98, 1282-1289 (2006) (Pubitemid 43948083)
106. C. W. Kim, H. K. Kim, M. T. Vo, H. H. Lee, H. J. Kim, Y. J. Min, W. J. Cho and J. W. Park: Tristetraprolin controls the stability of cIAP2 mRNA through binding to the 3'UTR of cIAP2 mRNA. Biochem Biophys Res Commun 400, 46-52 (2010)
107. M. Marderosian, A. Sharma, A. P. Funk, R. Vartanian, J. Masri, O. D. Jo and J. F. Gera: Tristetraprolin regulates cyclin D1 and c-myc mRNA stability in response to rapamycin in an akt-dependent manner via p38 mapk signaling. Oncogene 25, 6277-6290 (2006) (Pubitemid 44564744)
108. R. L. Ogilvie, M. Abelson, H. H. Hau, I. Vlasova, P. J. Blackshear and P. R. Bohjanen: Tristetraprolin downregulates IL-2 gene expression through AU-rich elementmediated mRNA decay. J Immunol 174, 953-961 (2005) (Pubitemid 40094291)
109. G. Stoecklin, X. F. Ming, R. Looser and C. Moroni: Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway. Mol Cell Biol 20, 3753-3763 (2000) (Pubitemid 30314475)
110. G. Stoecklin, P. Stoeckle, M. Lu, O. Muehlemann and C. Moroni: Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements. RNA 7, 1578-1588 (2001) (Pubitemid 33078933)
111. G. Stoecklin, S. A. Tenenbaum, T. Mayo, S. V. Chittur, A. D. George, T. E. Baroni, P. J. Blackshear and P. Anderson: Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J Biol Chem 283, 11689-11699 (2008)
112. U. Jalonen, R. Nieminen, K. Vuolteenaho, H. Kankaanranta and E. Moilanen: Down-regulation of tristetraprolin expression results in enhanced IL-12 and MIP-2 production and reduced MIP-3alpha synthesis in activated macrophages. Mediators Inflamm 2006, 40691 (2006)
113. R. L. Ogilvie, J. R. Sternjohn, B. Rattenbacher, I. A. Vlasova, D. A. Williams, H. H. Hau, P. J. Blackshear and P. R. Bohjanen: Tristetraprolin mediates interferon-gamma mRNA decay. J Biol Chem 284, 11216-11223 (2009)
114. M. Fechir, K. Linker, A. Pautz, T. Hubrich, U. Forstermann, F. Rodriguez-Pascual and H. Kleinert: Tristetraprolin regulates the expression of the human inducible nitric-oxide synthase gene. Mol Pharmacol 67, 2148-2161 (2005) (Pubitemid 41007794)
115. H. H. Lee, M. T. Vo, H. J. Kim, U. H. Lee, C. W. Kim, H. K. Kim, M. S. Ko, W. H. Lee, S. J. Cha, Y. J. Min, D. H. Choi, H. S. Suh, B. J. Lee, J. W. Park and W. J. Cho: Stability of the LATS2 tumor suppressor gene is regulated by tristetraprolin. J Biol Chem 285, 17329-17337 (2010)
116. H. Yu, S. Stasinopoulos, P. Leedman and R. L. Medcalf: Inherent instability of plasminogen activator inhibitor type 2 mRNA is regulated by tristetraprolin. J Biol Chem 278, 13912-13918 (2003) (Pubitemid 36799932)
117. S. A. Brooks, J. E. Connolly and W. F. Rigby: The role of mRNA turnover in the regulation of tristetraprolin expression: Evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway. J Immunol 172, 7263-7271 (2004) (Pubitemid 38747585)
118. T. J. Horner, W. S. Lai, D. J. Stumpo and P. J. Blackshear: Stimulation of polo-like kinase 3 mRNA decay by tristetraprolin. Mol Cell Biol 29, 1999-2010 (2009)
119. S. I. Gringhuis, J. J. Garcia-Vallejo, B. van Het Hof and W. van Dijk: Convergent actions of I-kappaB kinase beta and protein kinase C delta modulate mRNA stability through phosphorylation of 14-3-3 beta complexed with tristetraprolin. Mol Cell Biol 25, 6454-6463 (2005) (Pubitemid 41023221)
120. W. S. Lai, J. S. Parker, S. F. Grissom, D. J. Stumpo and P. J. Blackshear: Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol Cell Biol 26, 9196-9208 (2006) (Pubitemid 44904416)
121. P. Briata, C. Ilengo, G. Corte, C. Moroni, M. G. Rosenfeld, C. Y. Chen and R. Gherzi: The wnt/betacatenin-> pitx2 pathway controls the turnover of pitx2 and other unstable mRNAs. Mol Cell 12, 1201-1211 (2003) (Pubitemid 37487928)